The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback